Valion Bio, Inc. Total Liabilities and Equity
Valion Bio, Inc. (VBIO) had Total Liabilities and Equity of $32.47 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $32.47M.
- 2026-03-31: Liabilities and Equity $38.22M.
- 2025-12-31: Liabilities and Equity $31.61M.
- 2025-09-30: Liabilities and Equity $6.23M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $32.47M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $38.22M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $31.61M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.23M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $4.51M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.78M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.81M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $3.39M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.78M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $3.29M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $5.16M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $7.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.60M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.10M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.88M 10-K · filed 2024-03-25 | $5.86M 10-K · filed 2023-03-31 |
| 2022-09-30 | $8.21M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $11.03M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $12.69M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $15.04M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |